Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Treasury Shares (2024 - 2025)

Kairos Pharma's Treasury Shares history spans 2 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 1393.48% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, up 1393.48%, while the annual FY2025 figure was $4.2 million, 1393.48% up from the prior year.
  • Treasury Shares reached $4.2 million in Q4 2025 per KAPA's latest filing, up from $3.9 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $4.2 million in Q4 2025 to a low of $278188.0 in Q3 2024.